<li>Simon Mead, Azadeh Khalili-Shirazi, Caroline Potter, Tzehow Mok, Akin Nihat, Harpreet Hyare, Stephanie Canning, Christian Schmidt, Tracy Campbell, Lee Darwent, Nicola Muirhead, Nicolette Ebsworth, Patrick Hextall, Madeleine Wakeling, Jacqueline Linehan, Vincenzo Libri, Bryan Williams, Zane Jaunmuktane, Sebastian Brandner, Peter Rudge, John Collinge. <strong>Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme</strong>. <em>The Lancet Neurology</em>, 2022; 21 (4): 342 DOI: <a href="http://dx.doi.org/10.1016/S1474-4422(22)00082-5" rel="nofollow" target="_blank">10.1016/S1474-4422(22)00082-5</a>
</li>